Evidence map›Paper›PMID 35408734›Full record

ReviewMolecules (Basel, Switzerland)2022

Lycopene: A Potent Antioxidant for the Amelioration of Type II Diabetes Mellitus.

Hui Eng Leh, Lai Kuan Lee

Registry-linked trialAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07255170 (DEVELOPMENT OF "GLYCEMIC CONTROL BAR WITH BEANS AND TOMATO FOR DIABETIC EATING"), which is not on this map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07255170 naactive not recruitingnot on this mapstarted 2025, after this paper: background citation

Development of "glycemic control bar with beans and tomato for diabetic eating" (glycobite) snack bar formulations as a healthy snack for diabetes mellitus patients

TypeinterventionalSponsorUniversity Ngudi WaluyoRan2025 to 2025Enrolled100ConditionsDiabetes MellitusArmsThe GlycoBite snack bar formula created is to combine tomatoes and red beans in a ratio of 60% and 40% respectively. Participants consuming 40 grams of "GlycoBite" snack bars daily
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Lycopene Inhibits PRRSV Replication by Suppressing ROS Production.International journal of molecular sciences · 2025
    Article
  9. Article
  10. Review
  11. Timbe (Pharmaceuticals (Basel, Switzerland) · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Article
  18. Review
  19. Metabolomic Analysis of Carotenoids Biosynthesis byMolecules (Basel, Switzerland) · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hui Eng LehFood Technology Program, School of Industrial Technology, Universiti Sains Malaysia, Gelugor 11800, Pulau Pinang, Malaysia.
Lai Kuan LeeFood Technology Program, School of Industrial Technology, Universiti Sains Malaysia, Gelugor 11800, Pulau Pinang, Malaysia.ORCID 0000-0003-0638-0799

Funding

Ministry of Education Malaysia (FRGS) FRGS/1/2020/SKK05/USM/02/1
6 · The paper itself

Abstract

Nutrition is of utmost importance in chronic disease management and has often been described as the cornerstone of a variety of non-communicable diseases. In particular, type II diabetes mellitus (T2DM) represents a prevalent and global public health crisis. Lycopene, a bright red carotenoid hydrocarbon found in tomatoes and other red fruits and vegetables, has been extensively studied for its biological activities and treatment efficiency in diabetes care. Epidemiological investigations indicate that lycopene has potential antioxidant properties, is capable of scavenging reactive species, and alleviates oxidative stress in T2DM patients. This review aims to summarize the characteristics and mechanisms of action of lycopene as a potent antioxidant for T2DM. In addition, the evidence demonstrating the effects of lycopene on glycemic control and oxidative stress biomarkers in T2DM are also highlighted using animal and human studies as literature approach.

Indexed as

AntioxidantsDiabetes Mellitus, Type 2AnimalsCarotenoidsHumansLycopeneOxidative StressAntioxidantsCarotenoidsLycopeneantioxidantcomplementary medicinelycopeneoxidative stresstype II diabetes mellitus

Identifiers

PMID35408734
PMCPMC9000630

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.